Medulloblastoma: all 242 studies
Page 2 of 3. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.
- TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or MedulloblastomaCompletedNCT00867568Phase 1Results posted
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other MalignancyCompletedNCT00716976Phase 3Results posted
- Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or MedulloblastomaCompletedNCT00601003Phase 2Results posted
- A Study of Pemetrexed in Children With Recurrent CancerCompletedNCT00520936Phase 2Results posted
- Combination of Irinotecan and Temozolomide in Children With Brain Tumors.CompletedNCT00404495Phase 2Results posted
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNETCompletedNCT00392327Phase 3Results posted
- Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade GliomaCompletedNCT00381797Phase 2Results posted
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk MedulloblastomaCompletedNCT00336024Phase 3Results posted
- Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or PineoblastomaCompletedNCT00105560Not applicableResults posted
- Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System TumorsCompletedNCT00095940Phase 1/2Results posted
- Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk MedulloblastomaCompletedNCT00085735Phase 3Results posted
- Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid TumorCompletedNCT00085202Phase 3Results posted
- Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With MedulloblastomaCompletedNCT00058370Not applicableResults posted
- Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed MedulloblastomaTerminatedNCT00031590Phase 2Results posted
- Parental Distress and Treatment Adherence in Pediatric Recurrent MedulloblastomaWithdrawnNCT07660458
- RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)Active, not recruitingNCT07492316Phase 1
- Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large ModelsCompletedNCT06822842
- PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and EpendymomaSuspendedNCT06639607Phase 1/2
- Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS MalignanciesWithdrawnNCT06466798Phase 1
- Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain TumorsTerminatedNCT05934630
- Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS TumorsActive, not recruitingNCT05835687Phase 1
- Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid TumorsTerminatedNCT05429502Phase 1
- A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsCompletedNCT05199584Phase 2
- NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid TumorsStatus unknownNCT05131763Phase 1
- Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle StudyActive, not recruitingNCT05128903Phase 2
- Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma ResectionStatus unknownNCT05125666Phase 2
- 131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young AdultsNo longer availableNCT05064306
- A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine GliomaActive, not recruitingNCT04978727Phase 1
- Dual Task Training On Children With Ataxia After Medulloblastoma ResectionCompletedNCT04860934Not applicable
- Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in MonotherapyActive, not recruitingNCT04758533Phase 1/2
- 131I-Omburtamab, in Recurrent Medulloblastoma and EpendymomaActive, not recruitingNCT04743661Phase 2
- Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or MedulloblastomaActive, not recruitingNCT04661384Phase 1
- Physical Activity on Postural Stability and Coordination in Children With Posterior Fossa TumorCompletedNCT04528316Not applicable
- Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain CancerWithdrawnNCT04521946Phase 1
- Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed MedulloblastomaTerminatedNCT04402073Phase 2
- Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid TumorsActive, not recruitingNCT04337177Phase 1
- WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain TumorsCompletedNCT04334863Phase 1
- Infusion of Panobinostat (MTX110) Into the Fourth Ventricle in Children and Adults with Recurrent MedulloblastomaCompletedNCT04315064Early Phase 1
- NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid TumorsWithdrawnNCT04270461Phase 1
- Child's Study of the Impact of PF Lesion on Motor Skills, Language, Cognitive Functioning and Social CognitionStatus unknownNCT04174820
- Metabolomic Analysis of Body Fluid of Medulloblastoma in ChildrenStatus unknownNCT04065204
- Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPGActive, not recruitingNCT04049669Phase 2
- Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain TumorsCompletedNCT04023669Phase 1
- StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal CordWithdrawnNCT03990597Phase 1
- Fimepinostat in Treating Brain Tumors in Children and Young AdultsActive, not recruitingNCT03893487Early Phase 1
- A Phase 1 Study of ZSP1602 in Participants With Advanced Solid TumorsStatus unknownNCT03734913Phase 1
- Study of Tomotherapy HD in MedulloblastomaStatus unknownNCT03675230Not applicable
- EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS TumorsCompletedNCT03638167Phase 1
- DOTATOC PET/CT for Imaging NET PatientsActive, not recruitingNCT03583528
- HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS TumorsActive, not recruitingNCT03500991Phase 1
- Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and SarcomasActive, not recruitingNCT03478462Phase 1
- SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
- Components of Social Functioning in Survivors of Pediatric Brain TumorsCompletedNCT03361033
- PEP-CMV in Recurrent MEdulloblastoma/Malignant GliomaActive, not recruitingNCT03299309Phase 1
- Children's and Adolescents' Medulloblastoma Molecular Subgroups in ChinaStatus unknownNCT03288168
- Rare CNS Tumors Outcomes &RiskCompletedNCT03251989
- Dosimetry Guided PRRT With 90Y-DOTATOCWithdrawnNCT03013387Phase 2
- Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesTerminatedNCT02967380Not applicable
- Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRTCompletedNCT02962167Phase 1
- HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal TumorsActive, not recruitingNCT02875314Phase 4
- A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory MedulloblastomaCompletedNCT02748135Phase 1
- Social Cognition and Brain Integrity in Survivors of Pediatric MedulloblastomaCompletedNCT02747576
- Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven MedulloblastomaActive, not recruitingNCT02724579Phase 2
- Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid TumorsWithdrawnNCT02689336Phase 2
- Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain TumorsTerminatedNCT02684071Phase 2
- Radiation Therapy and Combination Chemotherapy for MedulloblastomaStatus unknownNCT02681705Phase 2
- Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsActive, not recruitingNCT02650401Phase 1/2
- Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain TumorsCompletedNCT02644291Phase 1
- Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS TumorsActive, not recruitingNCT02574728Phase 2
- Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain TumorsCompletedNCT02502708Phase 1
- Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain TumorsCompletedNCT02444546Phase 1
- Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or MedulloblastomaActive, not recruitingNCT02359565Phase 1
- Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain TumorsCompletedNCT02271711Phase 1
- Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or EpendymomaCompletedNCT02238899
- Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsWithdrawnNCT02194452Not applicable
- International Society of Paediatric Oncology (SIOP) PNET 5 MedulloblastomaActive, not recruitingNCT02066220Phase 2/3
- Metformin for Brain Repair in Children With Cranial-Spinal Radiation for MedulloblastomaCompletedNCT02040376Phase 3
- Study of Sequential High-dose Chemotherapy in Children With High Risk MedulloblastomaTerminatedNCT02025881Phase 1/2
- p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System TumorsCompletedNCT01975116Phase 1
- A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed MedulloblastomaActive, not recruitingNCT01878617Phase 2
- Valproic Acid in Childhood Progressive Brain TumorsWithdrawnNCT01861990Phase 1
- Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult MedulloblastomasStatus unknownNCT01857453Phase 2
- A Study of LY2940680 in Pediatric Medulloblastoma or RhabdomyosarcomaWithdrawnNCT01697514Phase 1
- Multicenter Pilot-study for the Therapy of Medulloblastoma of AdultsCompletedNCT01614132Phase 1/2
- Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog PathwayTerminatedNCT01601184Phase 1/2
- Auto Transplant for High Risk or Relapsed Solid or CNS TumorsCompletedNCT01505569Not applicable
- Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System TumorsCompletedNCT01445288
- Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma (PNET4)CompletedNCT01351870Phase 3
- Aflac ST0901 CHOANOME - Sirolimus in Solid TumorsCompletedNCT01331135Phase 1
- Yoga Therapy in Treating Patients With Malignant Brain TumorsTerminatedNCT01234805Not applicable
- Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and ChemotherapyWithdrawnNCT01233479Not applicable
- An East Asian Study of LDE225CompletedNCT01208831Phase 1
- Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain TumorCompletedNCT01171469Phase 1
- RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaCompletedNCT01119599Phase 1
- A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid TumorsCompletedNCT01106508Phase 1
- Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTerminatedNCT01088763Phase 1
- Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsCompletedNCT01076530Phase 1
- Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and LymphomaCompletedNCT00994500Phase 1
- A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS TumorsCompletedNCT00994071Phase 1
- Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell TumorsStatus unknownNCT00983398Phase 1/2